Introduction
Antilymphocyte globulin (A.L.G.) has been shown in many instances to possess immunosuppressive effects against cellular and, to a less extent, against humoral immunity (James, 1967) . The most effective preparation described is that of Lance and Medawar (1968) A cadaveric renal transplant programme has been in operation in Auckland since May 1966. Seventy-four kidneys have been transplanted into 62 recipients. Antihuman A.L.G. was prepared in horses in a manner similar to that of Iwasaki et al. (1967) . The main differences were the use, as antigen, of fresh frozen spleen cells rather than viable cells, and of diethylaminoethanol-Sephadex separation of the IgG fraction of serum instead of ammonium sulphate precipitation.
This preparation was given as part of their immunosuppressive therapy to 18 recipients of cadaveric renal transplants. The clinical details of these cases are compared and contrasted with those of 20 patients treated without A.L.G. during the previous 12 months. * Preparation of A.L.G.
Human spleens were obtained at operation or within 30 minutes of death, perfused with normal saline, and stored at -30°C. Cell suspensions were prepared by sieving splenic tissue just before being injected into the horse. Two horses received weekly injections of 1-2 x 1010 splenic cells given subcutaneously into multiple sites for four weeks. A further 15 injections were given at intervals over the next six months. Leucoagglutinin titres increased to 1: 1,280 and 1: 2,560 in each horse within three months and remained in this range for the next four months.
Thymic material was obtained at open-heart surgery or at neonatal necropsy and stored at -300 C. until cell suspensions were prepared before injection. A third horse received 0 5 x 100 thymic cells intravenously weekly for four weeks and subcutaneously and intradermally on six occasions in the next two months. Leucoagglutinin titres reached 1: 1,024.
Seven litres of blood was removed from each horse on several occasions after high levels of leucoagglutinins were observed. The serum was absorbed against pooled A, B, and 0 red cells and against group 0 inactivated serum.
The IgG fraction of the serum was concentrated by a batch technique using diethylaminoethanol-Sephadex (Perper et al., 1967) . The IgG fraction was dialysed against distilled water for three days, lyophilized, and reconstituted in phosphate buffer to yield a protein concentration of less than 5 g./100 ml., which was sterilized by passage through a Millipore filter. The leucoagglutinin titre of the final product varied between 1: 1,024 and 1: 32,000. The highest haemagglutinin titre was 1: 128. Platelet antibody titres were 1: 32 to 1:128. Onie batch of A.L.G. was also absorbed with human liver or muscle powder without reduction in leucoagglutinin titre.
After treatment with diethylaminoethanol-Sephadex antithymocyte globulin was concentrated in an Amicon ultrafiltration cell of 2-litre capacity with an XM 100 membrane, instead of receiving prolonged dialysis against distilled water and lyophilization.
The final A.L.G. or antithymocyte globulin contained 90 to 95 % IgG as determined by starch gel electrophoresis and densitometer scanning. Leucoagglutinin titres were determined by a modification of the method described by Payne (1964 An average of 1 4 reversible rejection episodes was seen during the four months following transplantation in the patients who received A.L.G. For the remaining 14 patients not receiving A.L.G., whose kidneys functioned for at least four months, the mean number of rejection episodes was 2 4 for the same period (0 1>P>0 05).
Renal function for the two groups of patients was assessed for kidneys which survived for at least four months after transplantation at the end of this period. No significant difference between them is seen (see Table) .
The mean daily dose of prednisone and of azathioprine for the first four months after transplantation were compared. The daily dose of prednisone for the A.L.G. , usually did not diminish with continued treatment. Apart from one patient in whom pronounced hypotension was regularly produced, the withdrawal of treatment was not mandatory and no anaphylactic reaction was observed.
Results in this study are comparable to those reported by Starzl et al. (1968) , who produced a similar type of A.L.G. which was concentrated by ammonium sulphate precipitation and prepared with viable spleen cells as antigen. These workers used living related donors as the source of the transplanted kidney. A significant reduction in prednisone dose, decrease in rejection episodes, and increase in kidney survival for one year were observed. Significant toxicity was also described by this group, though treatment was rarely interrupted for this reason (Kashiwagi et al., 1968) . Konomi et al. (1968) prepared A.L.G., using viable spleen cells as antigen, but concentrated the A.L.G. fraction with diethylaminoethanol-Sephadex as in the present study. Both immunosuppressive effect and toxicity appeared to be less than that described by Starzl et al. (1968) . Traeger et al. (1969) used thoracic duct lymphocytes as antigen and claimed improved results following renal transplantation when this preparation of A.L.G. was used. Significant toxicity was observed when the preparation was given by intramuscular injection, but when given intravenously the toxic effects were significantly reduced. Tsirimbas et al. (1968) prepared A.L.G. using lymphocytes from several different sources as antigen. When their preparation was given by intravenous injection, in a relatively high dose up to 10-20 ml. daily, little toxicity was observed and immunosuppressive effect was evident (Brendel, 1969) . Antithymocyte globulin, as prepared by Shorter et al. (1968) and by Sheil and Rogers (1969) . Reports of Brendel (1969) and Traeger et al. (1969) indicate that the intravenous injection of well-absorbed A.L.G. has not been associated with serious side-effects, and the immediate reactions are considerably less than when the preparation was given intramuscularly. The presence of precipitating antibodies against horse protein in most of the patients who received A.L.G., however, makes caution essential, since circulating antigen-antibody complexes are likely to be produced, with the risk of affecting the transplanted kidney.
The hypotensive effect of our preparation did not appear to be due to antibody-antigen interaction, since the first injection sometimes led to hypotension within one minute. Hypotension was also observed in rats given A.L.G., and the hypotensive effect in man could be reduced by prolonged dialysis against distilled water, in contrast to absorption with human-tissue powders, which had little effect.
The high incidence of " transplant lung " (Slapak et al., 1968) in patients treated with A.L.G. deserves comment. Four patients treated with this material developed a syndrome of dyspnoea, unproductive cough, low arterial Po2, poor carbon monoxide diffusion, and often a diffuse mottling of the lung fields on x-ray examination. At least six patients not receiving A.L.G. have also been observed in this unit. The appearance of this svndrome in 10 of the 62 cases receiving renal transplants is in contrast to the much lower incidence in other units, and suggests the presence of an endemic infective agent. Pneumocystis carinii has been found in the lungs of seven of the cases and may be the agent responsible for this syndrome. The role of A.L.G. in these cases is in doubt, especially as three had also received high doses of prednisone in the period just before the syndrome appeared.
A major probem in the preparation of a satisfactory A.L.G. for use in man is the lack of a convenient method of assaying its effectiveness without clinical trial. A lack of correlation between leucoagglutinin or lymphocyte toxicity titres and immunosuppression of A.L.G. has been noted by several investigators (Jeejeebhoy and Vela-Martinez, 1968) . Several potentially useful assay systems have been proposed. Balner et al. (1968) showed a close correlation between immunosuppression in man and prolongation of skin homograft survival in chimpanzees. Bach et al. (1969) reported that potent A.L.G. will inhibit the normal formation of rosettes when sheep red blood cells are incubated with lymphocytes which are producing antisheep red cell antibodies, and this system appears promising as a predictive test. Martin and Miller (1969) developed an assay based on the opsoninizing activity of A.L.G. Using a variation of this technique, Dr. Martin (personal communication) has assayed two batches of our A.L.G. and reported activity in one. The second batch showed some activity, but significantly less than the first. It was not possible to determine any difference in immunosuppressive effect between the two batches.
Some preparations of A.L.G. appear in man to have significant immunosuppressive properties. Toxicity is a major problem with most reported preparations, but it seems likely that this will be substantially reduced by using lymphocytes from a source other than the spleen as antigen, by absorption with other human-tissue powders, and by improved techniques of purifying and concentrating the active globulin. 
